MPTP公司
多巴胺能
黑质
纹状体
神经退行性变
帕金森病
多巴胺
神经保护
神经科学
神经毒素
药理学
医学
内科学
心理学
疾病
作者
Wenda Jiang,Zhejian Wang,Yiyang Jiang,Meili Lü,Xin Li
出处
期刊:Pharmacology
[Karger Publishers]
日期:2015-01-01
卷期号:96 (1-2): 25-31
被引量:20
摘要
<b><i>Aims:</i></b> Parkinson's disease (PD) is a neurodegenerative disorder characterized by loss of dopaminergic neurons in the substantia nigra (SN) and diminished dopamine levels in the striatum. Accumulating evidence supported that ginsenoside Rg1, the major pharmacologically active compound of ginseng, has a wide range of neurotrophic and neuroprotective effects under physiological and pathological conditions. Although Rg1 administration protects dopaminergic neurons in a rat model of PD, it is unclear if Rg1 treatment ameliorates motor function in PD. <b><i>Methods:</i></b> Using the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) that causes dopaminergic neurodegeneration, we investigated the effect of Rg1 on 3 tests of motor behaviors in mice: the accelerating rotarod, wire suspension and pole tests. <b><i>Results:</i></b> The results showed that Rg1 treatment (10 mg/kg, i.p.) succeeded in restoring motor functions to physiological level in MPTP-treated mice. Importantly, these behavioral ameliorations were accompanied by an attenuation of the MPTP-induced loss of dopaminergic neurons in the SN and striatum. <b><i>Conclusions:</i></b> These findings indicate that Rg1 can significantly rescue the deficit of motor function in mice model of PD, and suggest that Rg1 may be a potential therapeutic agent against PD and related disorders.
科研通智能强力驱动
Strongly Powered by AbleSci AI